Deutsche Bank Ag\ Ampio Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.16 - $0.47 $18,548 - $54,484	-115,925 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.42 - $0.62 $5,272 - $7,783	-12,554 Reduced 9.77%	115,925 $55,000
Q4 2021 Feb 11, 2022	BUY	$0.56 - $1.71 $3,502 - $10,696	6,255 Added 5.12%	128,479 $73,000
Q3 2021 Nov 04, 2021	SELL	$1.21 - $1.8 $1,034 - $1,539	-855 Reduced 0.69%	122,224 $203,000
Q2 2021 Aug 11, 2021	BUY	$1.56 - $1.98 $192,003 - $243,696	123,079 New	123,079 $206,000
Q1 2020 May 14, 2020	SELL	$0.36 - $0.74 $8,082 - $16,613	-22,450 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$0.35 - $0.58 $18,054 - $29,918	-51,584 Reduced 69.68%	22,450 $13,000
Q3 2019 Nov 14, 2019	BUY	$0.38 - $0.52 $18,713 - $25,607	49,246 Added 198.67%	74,034 $37,000
Q2 2019 Aug 14, 2019	SELL	$0.39 - $0.7 $38,568 - $69,225	-98,893 Reduced 79.96%	24,788 $9,000
Q1 2019 May 15, 2019	SELL	$0.43 - $0.68 $2,000 - $3,163	-4,652 Reduced 3.62%	123,681 $68,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $0.7 $156,173 - $280,311	-400,445 Reduced 75.73%	128,333 $50,000
Q3 2018 Dec 21, 2021	BUY	$0.44 - $3.02 $11,347 - $77,882	25,789 Added 5.13%	528,778 $269,000
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $22,357 - $153,452	50,812 Added 11.24%	502,989 $253,000
Q2 2018 Apr 21, 2020	BUY	$1.66 - $3.82 $42,736 - $98,345	25,745 Added 6.04%	452,177 $995,000
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $32,773 - $75,418	-19,743 Reduced 4.42%	426,432 $937,000
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $963,476 - $1.55 Million	446,054 Added 368639.66%	446,175 $1.52 Million
Q3 2017 Nov 14, 2017	BUY	$0.38 - $0.66 $45 - $79	121	121 $0

Others Institutions Holding AMPE

# of Institutions

Shares Held

96.6K

Call Options Held

Put Options Held

Ntb Financial Corp Centennial, CO

96.6K
Shares

$0
0.01% of portfolio

View Full List

About Ampio Pharmaceuticals, Inc.

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

More about AMPE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account